Expert NetworkExpert InterviewZEAL

Slingshot members are talking to an expert! The topic is:

Delving into the phase 2 data on Zealand Pharmaceuticals' Petrelintide, an amylin analog for weight loss and obesity.

Executed on:Mar 17, 2026 3:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Harvard Medical School
  • Medical Director, Obesity Clinic Program and Inpatient Diabetes Program & Associate Professor at Harvard Medical School.
  • Manages ~1,000 patients with diabetes and obesity
  • Research interests include diabetes and obesity, metabolic syndrome and obesity and cardiovascular disease with a focus on understanding metabolic and cardiovascular benefits of lifestyle changes and weight loss. 

Interview Goal

This conversation will examine the future of the weight management space and discuss the differences between GLP-1 based medications and long-acting amylin analogs. It will also feature a close look at Zealand's Phase 2 results for Petrelintide.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.